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Background
Lymphocyte proliferation assay has been the standard
assay to assess CD4+ T cell function. To determine lym-
phoproliferative responses (LPR) to HIV-1 p24 and
mitogens of PBMC from HIV-1 subtype CRF01_AE
infected Thai patients compared with PBMC from HIV-1
seronegative donors.
Methods
Frozen PBMC from 8 HIV-1 infected Thai patients and 8
HIV-seronegative donors were tested and compared for
LPR to multiple concentrations of HIV-1 p24 antigen,
phytohemagglutinin (PHA), and pokeweed mitogen
(PWM). HIV-1 infected patients were grouped by the pres-
ence of CD4+ counts > 350 [mean = 483.5 cell/mm3, n =
2 (group A)] or CD4+ counts < 350 [median = 75.5 cells/
mm3, n = 6 (group B)]. A stimulation index > 5 was con-
sidered a positive LPR.
Results
Both HIV-1 infected patients and HIV-seronegative
donors Thai demonstrated positive LPR to PHA and PWM
(8/8, 100%). LPR to HIV-1 p24 were seen only patients in
group A (100%, 2/2), not in group B (0%, 0/6). This dif-
ference was significant (Chi-square test = 11.0, p =
0.0357).
Conclusion
This result suggests that CD4+ T cells in HIV-1 subtype
CRF01_AE infected Thai patients with CD4+ counts >350
cells/mm3 have ability to proliferate in response to HIV-1
p24 and indicate they remained the good CD4+ T cell
function.
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